Warrants
Long-dated contracts on new shares, with terms that differ instrument by instrument and live only in the agreement.
Warrants are issued by companies, not standardized by an exchange, so every warrant is its own contract. The terms that determine what the instrument is worth — the redemption trigger, the exercisability condition, the change-of-control treatment, the expiration — are in an agreement filed as an exhibit. Warrants are the clearest case in the market where reading the filing is not optional.
In detail
The warrant market is under-covered because it is unglamorous and because it does not summarize. Two warrants on the same company, issued eighteen months apart, can have entirely different redemption thresholds, different anti-dilution provisions, and different behavior in a merger. There is no standard contract. A data vendor's field labeled "expiration" is a transcription of one term from one document, and it is silently wrong often enough to matter. The theme spans the whole market — IPO-unit warrants, SPAC warrants public and private, lender warrants, PIPE warrants, rights-plan instruments — without treating warrants as the frame for the whole site.
Following the theme through filings is the only method that works, because the primary source is the warrant agreement, and it is filed. So are the amendments, the redemption notices with their fixed deadlines, the 8-Ks disclosing exercise-price adjustments, and the consent solicitations that change terms with a majority vote of holders who mostly never voted. The exercisability condition — many warrants cannot be exercised until a registration statement covering the underlying shares is effective — is a filing fact, checkable in minutes, and it is the difference between an instrument with value and an instrument that is temporarily inert.
What a filing-driven feed shows that headlines don't: redemption calls, which are the single most consequential event in a warrant's life and are typically covered nowhere, on a deadline measured in days; expirations, which are simply not announced and which a calendar built from agreements can anticipate; the treatment of warrants in a merger, buried in an S-4 that everyone reads for the exchange ratio; and the quiet amendments that cash out or convert warrants on terms the common-stock coverage never mentions.
Signals: 8-K (Items 1.01, 3.03, 8.01) · S-1 / S-3 (resale registration of underlying shares) · 424B · S-4 · DEF 14A (warrant consent solicitations)
We report what was filed. We don't tell you what to do about it, and nothing here is investment advice.